Auditory sensory memory and the cholinergic system:: Implications for Alzheimer's disease

被引:74
|
作者
Pekkonen, E [1 ]
Hirvonen, J
Jääskeläinen, IP
Kaakkola, S
Huttunen, J
机构
[1] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland
[2] Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, SF-00100 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, BioMag Lab, Med Engn Ctr, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Dept Clin Neurophysiol, Helsinki, Finland
基金
芬兰科学院;
关键词
D O I
10.1006/nimg.2001.0805
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Auditory sensory memory represents one of the simplest types of short-term memory that can be studied electrophysiologically with mismatch negativity (MMN); a specific auditory event-related potential indexing automatic comparison of incoming stimuli to an existing memory trace. Previous results suggest that auditory sensory memory deteriorates in aging and especially Mi Alzheimer's disease (AD). It has remained unsettled, however, whether MMN is regulated by the cholinergic system, which is deteriorated in AD contributing to cognitive impairments. We recorded cortical auditory responses with a magnetometer from 13 healthy subjects after intravenous injection of scopolamine, centrally acting cholinergic antagonist, or glycopyrrolate, a drug with a peripheral anticholinergic properties without penetrating the blood-brain barrier, using a double-blind protocol. Scopolamine reduced MMNm amplitude in response to frequency, but not duration, change, increased P50m amplitude, and delayed N100m latency. These findings suggest that the cholinergic system regulates the frequency-specific comparison of incoming stimuli to existing memory trace and modulates the preattentive processing related to stimulus detection. Further, neural mechanisms responsible for cortical frequency- and duration-specific discrimination appear to have different sensitivities to cholinergic modulation. Auditory evoked potentials might be suitable to monitor cholinergic activity in AD. (C) 2001 Academic Press.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 50 条
  • [41] Cholinergic Aspects of Aging and Alzheimer's Disease
    Mesulam, Marsel
    BIOLOGICAL PSYCHIATRY, 2012, 71 (09) : 760 - 761
  • [42] Subcranial Cholinergic Ganglia in Alzheimer's Disease
    Schober, Ralf
    Hilbrich, Isabel
    Holzer, Max
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (06): : 503 - 503
  • [43] Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease
    Santos, Renato X.
    Correia, Sonia C.
    Cardoso, Susana
    Carvalho, Cristina
    Santos, Maria S.
    Moreira, Paula I.
    JOURNAL OF NEUROCHEMISTRY, 2011, 117 (06) : 927 - 936
  • [44] Cholinergic Drugs in Pharmacotherapy of Alzheimer's Disease
    Camps, P.
    Munoz-Torrero, D.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (01) : 12 - 26
  • [45] Update on cholinergic drugs in Alzheimer's disease
    Kumar, V
    Sugaya, K
    Saunders, S
    Mechanic, J
    DRUGS OF TODAY, 1996, 32 (07): : 529 - 537
  • [46] Nicotinic Cholinergic Mechanisms in Alzheimer's Disease
    Shen, Jianxin
    Wu, Jie
    NICOTINE USE IN MENTAL ILLNESS AND NEUROLOGICAL DISORDERS, 2015, 124 : 275 - 292
  • [47] Cholinergic foundations of Alzheimer's disease therapy
    Giacobini, E
    JOURNAL OF PHYSIOLOGY-PARIS, 1998, 92 (3-4) : 283 - 287
  • [48] Alzheimer's disease - Cholinergic therapy and beyond
    Sunderland, T
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1998, 6 (02): : S56 - S63
  • [49] The Cholinergic Neuronal Phenotype in Alzheimer's Disease
    Jan Krzysztof Blusztajn
    Brygida Berse
    Metabolic Brain Disease, 2000, 15 : 45 - 64
  • [50] The cholinergic neuronal phenotype in alzheimer′s disease
    Jan Krzysztof Blusztajn
    Brygida Berse
    Metabolic Brain Disease, 2000, 15 (1) : 45 - 64